Total Payments
$3,469
2019 Payments
$37.16
Companies
23
Transactions
224
Medicare Patients
27,506
Medicare Billing
$2.1M
Payment Breakdown by Category
Food & Beverage$3,457 (99.6%)
Education$12.50 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,457 | 222 | 99.6% |
| Education | $12.50 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $702.67 | 55 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $602.91 | 34 | $0 (2018) |
| Lundbeck LLC | $280.42 | 21 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $266.43 | 27 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $224.03 | 10 | $0 (2018) |
| Amarin Pharma Inc. | $171.77 | 9 | $0 (2019) |
| Allergan Inc. | $165.15 | 11 | $0 (2018) |
| Amgen Inc. | $160.60 | 8 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $152.94 | 7 | $0 (2018) |
| Gilead Sciences, Inc. | $149.74 | 8 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $37.16 | 2 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($22.34) |
| 2018 | $1,640 | 101 | Janssen Pharmaceuticals, Inc ($355.91) |
| 2017 | $1,791 | 121 | Novartis Pharmaceuticals Corporation ($367.28) |
All Payment Transactions
224 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/01/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/05/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Hypertriglyceridemia | ||||||
| 12/27/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.93 | General |
| Category: Cardiovascular | ||||||
| 12/20/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/14/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/13/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/13/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.91 | General |
| Category: Cardiovascular | ||||||
| 12/12/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/06/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.39 | General |
| Category: Cardiovascular | ||||||
| 12/05/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.39 | General |
| Category: Cardiovascular | ||||||
| 12/05/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $0.95 | General |
| Category: Cardiovascular | ||||||
| 11/30/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/28/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/27/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/16/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/14/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/14/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $0.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/01/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.54 | General |
| Category: Cardiovascular | ||||||
| 11/01/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $1.24 | General |
| Category: Cardiovascular | ||||||
| 10/29/2018 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/26/2018 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/24/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/19/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $8.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/18/2018 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 6,628 | 11,086 | $764,742 | $527,240 |
| 2022 | 32 | 7,196 | 12,365 | $804,875 | $561,302 |
| 2021 | 29 | 6,912 | 11,811 | $774,579 | $555,307 |
| 2020 | 35 | 6,770 | 10,858 | $692,928 | $492,669 |
Total Patients
27,506
Total Services
46,120
Medicare Billing
$2.1M
Procedure Codes
127
All Medicare Procedures & Services
127 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 946 | 2,328 | $356,464 | $240,317 | 67.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 446 | 454 | $115,019 | $77,302 | 67.2% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 250 | 251 | $74,460 | $51,981 | 69.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 1,043 | 2,454 | $46,425 | $29,760 | 64.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 116 | 116 | $24,003 | $15,406 | 64.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 44 | 220 | $20,959 | $15,301 | 73.0% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 249 | 250 | $17,661 | $11,653 | 66.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 580 | 880 | $12,775 | $11,546 | 90.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 474 | 687 | $12,594 | $11,308 | 89.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 58 | 58 | $14,510 | $10,012 | 69.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 587 | 901 | $10,069 | $9,325 | 92.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 618 | 985 | $8,750 | $8,138 | 93.0% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 98 | 98 | $9,490 | $5,746 | 60.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 42 | 49 | $8,584 | $5,700 | 66.4% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 249 | 250 | $9,369 | $5,447 | 58.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 418 | 631 | $5,281 | $4,802 | 90.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 57 | $6,496 | $3,956 | 60.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 35 | 35 | $4,712 | $3,374 | 71.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 32 | 32 | $2,294 | $2,248 | 98.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 65 | 76 | $854.54 | $723.52 | 84.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 33 | 34 | $671.50 | $657.90 | 98.0% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 52 | 73 | $658.12 | $605.17 | 92.0% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 18 | 18 | $688.48 | $367.56 | 53.4% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 16 | 16 | $464.80 | $359.36 | 77.3% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 13 | 13 | $386.75 | $295.36 | 76.4% |
About Dr. Francis Obrien, MD
Dr. Francis Obrien, MD is a Cardiovascular Disease healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1336148717.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Francis Obrien, MD has received a total of $3,469 in payments from pharmaceutical and medical device companies, with $37.16 received in 2019. These payments were reported across 224 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($3,457).
As a Medicare-enrolled provider, Obrien has provided services to 27,506 Medicare beneficiaries, totaling 46,120 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 127 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location New York, NY
- Active Since 07/19/2005
- Last Updated 07/08/2007
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1336148717
Products in Payments
- XARELTO (Drug) $702.67
- ENTRESTO (Drug) $602.91
- NORTHERA (Drug) $280.42
- ELIQUIS (Drug) $266.43
- Vascepa (Drug) $171.77
- PRADAXA (Drug) $152.94
- PRALUENT (Drug) $142.55
- BYSTOLIC (Drug) $110.51
- BRILINTA (Drug) $87.34
- Repatha (Biological) $85.48
- MULTAQ (Drug) $81.48
- Livalo (Drug) $75.39
- Corlanor (Drug) $75.12
- PRALUENT ALIROCUMAB INJECTION (Biological) $62.68
- CHANTIX (Drug) $47.59
- Veltassa (Drug) $46.12
- Synthroid (Drug) $40.95
- WATCHMAN (Device) $37.07
- Amitiza (Drug) $23.25
- XIFAXAN (Drug) $22.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in New York
Dr. Roger Hajjar, Md, MD
Cardiovascular Disease — Payments: $5.2M
Cardiovascular Disease $5.2M
Dr. Jacob Koruth, M.d, M.D
Cardiovascular Disease — Payments: $3.2M
Cardiovascular Disease $3.2M
Dr. Martin Leon, M.d, M.D
Cardiovascular Disease — Payments: $2.7M
Cardiovascular Disease $2.7M
Dr. Gregg Stone, M.d, M.D
Cardiovascular Disease — Payments: $2.2M
Cardiovascular Disease $2.2M
Adam Rosenbluth, Md, MD
Cardiovascular Disease — Payments: $1.5M
Cardiovascular Disease $1.5M
Dr. Deepak Bhatt, Md, MD
Cardiovascular Disease — Payments: $1.4M
Cardiovascular Disease $1.4M